Finance News – India
What is your interest today?
Stock Market
Stocks
Bse
Shares
Index
Sensex
Nse
Bse Sensex
Nifty
Points
Ipo
Rbi
Investors
Crore
Markets
Revenue
Net Profit
Sebi
Share Market
Target Price
Stock
Nse Nifty
Earnings
Inflation
Trade
Nifty50
Tariffs
Gold
Stake
Nifty 50
Profit
Rupee
Share Price
Fertilisers
Power Stocks
Sugar Stocks
Investment
Pat
Mining Stocks
Oil Prices
Federal Reserve
Volume
Block Deal
Equities
Bitcoin
Traded Value
Rate Cut
Dollar
Financials
Fmcg Stocks
Us Stocks
Wgc
Firstcry
Robert Kiyosaki
Moil
Indian Central Bank
Viyash Life Sciences
Holiday Calendar
Long Term Investing
Equity Mutual Funds
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Find stories in India outlets…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Economic Times Markets • Jun 10, 2025
JSW Steel, Aurobindo Pharma among 6 large & midcap firms with promoter pledge decline in Q4
Several prominent companies have reduced pledged shares in the last quarter, reflecting shifts in promoter confidence that may influence investor decisions amid sector-specific mar...
Read Full Article →
Economic Times Markets • May 27, 2025
Aurobindo Pharma shares jump 2% even as Q4 profit dips marginally to Rs 903 cr
Aurobindo Pharma experienced a slight decrease in quarterly profit despite increased revenue and overall annual earnings growth, driven by strong sales volumes and improved results...
Read Full Article →
Economic Times Markets • May 26, 2025
Aurobindo Pharma Q4 net dips marginally to Rs 903 cr; revenue at Rs 8,382 cr
Aurobindo Pharma’s consolidated profit after tax slightly decreased to Rs 903 crore in the fourth quarter ended March 2025, while its total revenue reached Rs 8,382 crore during th...
Read Full Article →